uniQure (QURE) Operating Expenses (2016 - 2026)
uniQure (QURE) recorded quarterly Operating Expenses of $49.5 million in Q1 2026, down 12.96% quarter-over-quarter from $56.8 million in Q4 2025, and up 4.69% on a YoY basis from $47.2 million in Q1 2025.
uniQure (QURE) Operating Expenses (2016 - 2026) Analysis & Trends
uniQure's Operating Expenses history runs 11 years deep, the most recent figure standing at $49.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 4.69% year-over-year to $49.5 million; the TTM figure through Mar 2026 stood at $210.0 million (up 5.99% YoY), while the FY2025 annual figure was $207.8 million, down 3.24% from the prior year.
- Operating Expenses was $49.5 million for Q1 2026 at uniQure, down from $56.8 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $84.5 million in Q3 2023 to a low of $43.2 million in Q3 2024.
- Historically, Operating Expenses has averaged $60.7 million across 5 years, with a median of $56.9 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 44.83% in 2023, then tumbled 48.87% in 2024.
- A 5-year view of Operating Expenses shows it stood at $78.2 million in 2022, then fell by 11.88% to $68.9 million in 2023, then dropped by 26.26% to $50.8 million in 2024, then grew by 11.79% to $56.8 million in 2025, then decreased by 12.96% to $49.5 million in 2026.
- The last three Operating Expenses figures came in at $49.5 million (Q1 2026), $56.8 million (Q4 2025), and $54.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 49.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.46 Mn |
| Dec 31, 2025 | 56.83 Mn |
| Sep 30, 2025 | 54.20 Mn |
| Jun 30, 2025 | 49.54 Mn |
| Mar 31, 2025 | 47.25 Mn |
| Dec 31, 2024 | 50.84 Mn |
| Sep 30, 2024 | 43.19 Mn |
| Jun 30, 2024 | 56.88 Mn |
| Mar 31, 2024 | 63.86 Mn |
| Dec 31, 2023 | 68.94 Mn |
| Sep 30, 2023 | 84.48 Mn |
| Jun 30, 2023 | 68.57 Mn |
| Mar 31, 2023 | 81.09 Mn |
| Dec 31, 2022 | 78.24 Mn |
| Sep 30, 2022 | 62.25 Mn |
| Jun 30, 2022 | 59.52 Mn |
| Mar 31, 2022 | 55.99 Mn |
| Dec 31, 2021 | 58.10 Mn |
| Sep 30, 2021 | 48.46 Mn |
| Jun 30, 2021 | 73.22 Mn |